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Flower Petal Stenting”
Novel Technique for the Treatment of Coronary Bifurcation Lesions
oshihisa Kinoshita, MD,* Osamu Katoh, MD,* Tetsuo Matsubara, MD,†
ariko Ehara, MD,* Kenya Nasu, MD,* Maoto Habara, MD,* Takahiko Suzuki, MD*
oyohashi and Nagoya, Aichi, Japan
bjectives We sought to report the results of both bench-testing and our ﬁrst clinical experience
ith this novel technique.
ackground The optimal stenting technique for bifurcation lesions has yet to be deﬁned.
ethods This technique works by ﬂaring the proximal side of the stent in side branch out like a
ower petal. We tested it in vitro and the resultant stent structure and stent polymer damage was
bserved in both main branch and side branch with an optical microscopy, multislice computer to-
ography, intravascular ultrasound, endoscopy, and by electron microscopy. We also applied this
echnique in 33 patients and assessed patient outcomes up to 9 months prospectively. Drug-eluting
tents were used for the bench tests and for all patients.
esults Bench-testing showed complete coverage of the bifurcation with minimal stent-layer over-
apping. There was little polymer damage by electron microscopy. Procedural success was achieved
n all cases and restenosis occurred in 2 cases. In both restenosis cases, “petal” stenting technique
as done reluctantly after another stent had already been deployed in the main branch before any
tenting of the side branch. There were no incidences of restenosis when this technique was used
lectively.
onclusions In terms of damage to the polymer and ostial strut coverage, this new “ﬂower petal
tenting” technique is effective for treatment of bifurcation lesion and it may well be superior to
ther available techniques. (J Am Coll Cardiol Intv 2010;3:58–65) © 2010 by the American College
f Cardiology Foundation
rom the *Division of Cardiology, Toyohashi Heart Center, Toyohashi, Aichi, Japan; and the †Division of Cardiology, Nagoya
eart Center, Nagoya, Aichi, Japan.anuscript received May 12, 2009; revised manuscript received July 27, 2009, accepted September 4, 2009.
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59oronary bifurcation lesions remain an unresolved problem
or the interventional cardiologist. Compared with nonbi-
urcation lesions, percutaneous coronary intervention (PCI)
f bifurcation lesions is associated with low procedural
uccess rates, high restenosis rates, and high periprocedural
omplication rates (1–3). To overcome these problems,
any different techniques of bifurcation stenting have been
roposed, such as V-stenting, T-stenting, crush stenting,
See page 66
ulottes stenting, and Y-stenting (4–8). In addition to these
ew techniques, drug-eluting stents (DES) were also intro-
uced into the market during the same period. The use of
ES improved outcomes for the main branch (MB), but
emonstrated the continuing occurrence of restenosis at the
stium of the side branch (SB). Under expansion and
ncomplete coverage at the ostium of SB are probable causes
f restenosis (9,10). To resolve these issues, we designed a
ew stenting technique, “flower petal stenting,” and evalu-
ted the mid-term outcomes after implantation of either
irolimus-eluting stents (Cypher, Cordis Corp., Warren,
ew Jersey) or paclitaxel-eluting stents (Taxus Express,
oston Scientific, Natick, Massachusetts) for bifurcation lesions
sing this novel technique.
aterials and Methods
rocedural description. We illustrated the different steps of
flower petal stenting” in Figure 1. The most important point
f this technique is to cover the carina completely with stent
truts. At first, a stent is deployed in the SB after insertion
f wires into both the MB (MBw1) and the SB (SBw). The
roximal marker of the SB stent is placed in the MB 1 to 2
m proximal to the carina of the bifurcation with only 1
trut protruding into the MB (Figs. 1A and 1B). A third
ire (MBw2) is then inserted through the strut of this stent,
hich is protruding into the MB (Figs. 1C and 1D) and the
trut is dilated with a balloon catheter to allow the stent
trut to contact the wall on the opposite side (Figs. 1E and
F). Appropriate balloon size was determined by using the
essel diameter of the MB as a reference. The first kissing
ilation is performed to attach the proximal stent strut to
istal left main (Fig. 1G). After retracting the balloon with
he MBw2 from the strut (Fig. 1H), a balloon catheter is
elivered over the MBw1 to turn over the protruding part of
he stent of the SB to distal in the MB while keeping the
alloon in the MB inflated at low pressures (up to 1 to 3
tm) (Figs. 1I to 1L). After that, the second kissing dilation
as performed. It was effective to use balloon proximal edge
o cover the carina completely by a stent strut from the SB
Figs. 1M and 1N). Finally, a stent was implanted in the
B (Figs. 1O and 1P) and final kissing dilation was
erformed. tIn vivo, MBw2 was often inserted using intravascular
ltrasound (IVUS) through the protruding strut in the MB.
espite IVUS guidance, it was difficult to insert the wire
hrough the protruding stent strut because either the pro-
ruding space was too small or the IVUS catheter interfered
ith wire manipulation of MBw2. Therefore, we developed
new method to pass both the guidewire and balloon
atheter through the strut outside the body before advancing
t into the coronary artery (Fig. 2).
ench-top test. We deployed either sirolimus- or paclitaxel-
luting stents using the flower petal stenting technique into
silicone bifurcation model with 3.0-mm diameter stent
nto the MB and 2.5-mm stent into the SB. Kissing balloon
ilation was then performed using 3.0/2.5-mm balloons for
he MB and SB, respectively. The stent structure was
bserved using an optical microscope, multislice computed
omography, and IVUS. An electron microscope was used
o visualize any polymer damage after deployment.
linical study. STUDY POPULA-
ION AND ANGIOPLASTY PRO-
EDURE. From May 2005 to
ecember 2008, 34 bifurcation
esions of 33 patients were
reated using the flower petal
tenting technique irrespective
f the type of the lesion. The
ifurcation lesion in this study
as defined as a diameter steno-
is50% involving the MB with
nvolvement of the origin or the
stium of the SB. Bifurcation
esions were classified according
o the Medina classification
11). Patients with contraindica-
ions to antiplatelet therapy were
xcluded. Written informed
onsents for the PCI procedure were received from all
atients.
All patients were pre-treated with aspirin (100 mg) and
ither ticlopidine (200 mg daily) or clopidogrel (75 mg
aily). During the procedure, patients received intravenous
eparin administration to maintain activated clotting times
etween 250 and 300 s. All procedures were performed
sing DES. After the procedures, all patients continued on
spirin and ticlopidine or clopidogrel for as long as toler-
ted. Procedural success was defined as a final residual
tenosis 30% in both branches without major adverse
ardiac events (MACE) at any time during the hospital stay.
e defined MACE as cardiac death, Q-wave or non–Q-
ave myocardial infarction (MI) and target vessel revascu-
arization, either percutaneous or surgical. All deaths were
onsidered cardiac in origin unless otherwise documented.
on–Q-wave MI was defined as creatinine kinase3 times
Abbreviations
and Acronyms
DES  drug-eluting stents
IVUS  intravascular
ultrasound
MACE  major adverse
cardiac events
MB  main branch
MI  myocardial infarction
PCI  percutaneous
coronary intervention
SB  side branch
TLR  target lesion
revascularization
w  wirehe upper limit of normal with elevated MB fraction.
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60-wave MI was defined as new pathological Q waves in
or more leads in addition to elevated enzymes as previ-
usly discussed. Target vessel revascularization was defined
Figure 1. How To Create the Original Flower Petal Stenting
Each step is explained in the text. The other wire (MBw2) was inserted throug
MBw  main branch wire; SBW  side branch wire.
Figure 2. The First Few Steps of Modified Flower Petal Stenting
(A) The stent cover is removed to expose the proximal single strut of the sten
ing the proximal single strut. (B) The stent cover is removed and before insert
catheter is passed through the proximal stent strut. (D) The expanded proxim
no longer be inserted more distally to the bifurcation. After these steps, the next prs repeat revascularization within the treated vessel. Target
esion revascularization (TLR) was defined as a repeat
evascularization with a stenosis 50% within the stent or
protruded strut under intravascular ultrasound guidance in clinical case C.
the stent delivery system balloon is inﬂated to 5 to 6 atm partially expand-
e stent, the third wire is inserted into the main branch. (C) Another balloon
t is held stationary and the stent with balloon catheter is inserted until it canh thet and
ing th
al struocedure follows step D in Figure 1.
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61-mm proximal or distal segments adjacent to the stent.
arget bifurcation revascularization was defined as a repeat
evascularization with a stenosis 50% within 5 mm prox-
mal or distal to the carina of bifurcation (12). Documented
tent thrombosis was defined as angiographic demonstra-
ion of stent closure or intrastent thrombus. Suspected stent
hrombosis was defined as unexplained sudden death or MI
ithout angiographic or visual confirmation.
Up to 9 months, MACE were followed with office visits
r telephone contact to all patients.
ngiographic analysis. Quantitative coronary angiography
as performed at baseline, after procedure, and at 9-month
ollow-up using a computer-based algorithm developed by
EDIS 5.1 (Medical Imaging System, Leiden, the Neth-
rlands). Quantitative angiographic measurements of target
esions were made at “in-stent” zone and “in-segment” zone,
hich includes both stented segment and margins 5 mm
roximal and distal to the stent. Binary restenosis was
efined as 50% diameter stenosis of the target lesion.
tatistic analysis. Continuous variables were presented as
ean  SD and were compared using paired t test.
ategorical variables were presented as counts and percent-
ges and compared using McNemar test. A p value 0.05
as considered significant. All data were processed using
he Statistical Package Social Science, version 11 (SPSS
nc., Chicago, Illinois).
esults
ench-top test. As shown in Figure 3, the proximal strut of
he stent in the SB was turned over to distal in the MB and
he proximal part of SB stent was opened widely. There was
o protrusion of stent strut from SB into MB (Fig. 4). Less
olymer damage was seen in the overlapping portion of
Figure 3. Verification With Optical Microscopy
The proximal strut of the stent in the side branch is opened widely and turnedtent (Fig. 5).linical study. Thirty patients were treated using the flower
etal stenting technique. Baseline clinical characteristics are
hown in Table 1 (13). Three of the 33 patients (9.1%) were
dmitted due to unstable angina pectoris, and 14 (42.4%)
uffered from diabetes mellitus. All patients were treated
well (white arrows). There is no underexpansion at side branch ostium (B).
Figure 4. Verification With MSCT, IVUS, and Endoscopy
(A) A multislice computed tomography (MSCT) image. Carina was covered
with stent in the side branch (SB). Images in the lower panel show intra-
vascular ultrasound (IVUS) (B) and endoscopy (C) images at the dotted
line in A, respectively. There was no protrusion of stent strut from SB into
main branch (MB) and the SB ostium was opened widely.
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62ith a dual antiplatelet regimen (aspirin  clopidogrel
ulfate or aspirin  ticlopidine).
Table 2 shows lesion characteristics. Type 1,1,1 bifurca-
ion lesion accounted for approximately half of our cases
47.1%). In most cases, the bifurcation angle was 70°
85.3%).
Table 3 shows procedural data and initial results. Proce-
ural success rate was 100%. In only 1 case, the flower petal
tenting could not be performed and a stent strut fracture
ccurred at the proximal portion. Fortunately, we were able
o obtain an optimal lumen of the side branch ostium using
issing balloon dilation. After the introduction of modified
ethod as shown in Figure 2, we were able to perform the
ower petal stenting successfully in all cases. Final kissing
alloon dilation was performed in all cases. Four cases were
ompleted with “reverse flower petal” stenting, by stenting
n the SB after the MB was stented. There were no
n-hospital MACE and 30-day MACE.
Figure 5. Verification With Electron Microscopy
(A) Overlapping portion of stent in the side branch. (B) A close-up image of th
stent in the side branch (white circles).
Table 1. Patient Characteristics (n  33)
Age, yrs 69.7  9.3
Male (%) 24 (72.7)
Hypertension (%) 24 (72.7)
Diabetes (%) 14 (42.4)
Hypercholesterolemia (%) 16 (48.5)
Smoking (%) 8 (24.2)
Family history of CAD (%) 9 (27.3)
Prior CABG (%) 0 (0)
Unstable angina (%) 3 (9.1)
CCS (%)
1–2 31 (93.9)
3–4 2 (6.1)
CABG coronary artery bypass graft; CAD coronary artery disease; CCSCanadian Cardiovas-cular Society angina classification class (13).Quantitative coronary angiographic analysis results for
oth the MB and the SB were summarized in Table 4.
inary restenosis occurred in 2 lesions in the SB only.
Clinical follow-up at 9 months was available in 78.8% of
atients with initial success for this technique (Table 5). Two
atients showed MACE and both required TLR by PCI.
ll TLR occurred only in cases when reverse flower petal
tenting was performed.
iscussion
e reported here the initial and mid-term results of this
ovel flower petal stenting technique for bifurcation lesion
tenting. Although the issue of restenosis, which is the
chilles’ heel of PCI, has improved with the introduction of
ES, restenosis remains to be an issue in some specific
esion types. Bifurcation lesion is 1 such lesion in this DES
ra. Restenosis at the ostium of the SB due to incomplete
ite box in A. Polymer damage was hardly seen in the overlapping portion of
Table 2. Lesion Characteristics (n  34)
Lesion location, cumulative
Distal LMT/LAD-DB/LCX-OM 28/3/3
Bifurcation type (%)
0,0,1 7 (20.6)
0,1,0 3 (8.8)
1,0,0 0
0,1,1 6 (17.6)
1,0,1 2 (5.9)
1,1,0 0
1,1,1 16 (47.1)
Calciﬁcation (%)
Main branch 12 (35.3)
Side branch 2 (5.9)
Angulation 70° (%) 5 (14.7)
DBdiagonal branch; LAD left anterior descending artery; LCX left circumflex artery; LMTe whleft main trunk; OM obtuse marginal.
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63overage and stent underexpansion (9,10) is still unresolved
egardless of the variety of bifurcation stenting methods
4–8) introduced with DES. There are many reasons why
dequate coverage and expansion at SB ostium cannot be
chieved. The first reason is the anatomy at the bifurcation.
n particular, the vessel size and bifurcation angle are
mportant factors because the shape of the ostium of the SB
epends on these 2 factors. The second reason is limitation
f stent platform. If the bifurcation angle is shallow, the
hape of SB ostium shifts from a circular shape into a more
val shape and the major axis is lengthened. Even when the
B 2.5 mm in diameter, the major axis becomes very
arge. For example, the major axis calculated using trigono-
etric function becomes 5 mm when the vessel diameter is
.5 mm and angle is 30° (Fig. 6). We showed differences of
B ostial diameter varied by bifurcation angle in Figure 7.
hen we put a stent in the MB in this condition, a stent
trut will definitely cover the ostium of the SB because there
Table 3. Procedural Characteristics and Initial Results (n  34)
Stents (%)
Only SES 25 (73.5)
Only PES 5 (14.7)
SES and PES 3 (8.8)
BMS and SES 1 (2.9)
Final kissing dilation (%) 34 (100)
Reverse ﬂower petal stenting (%) 4 (11.8)
Angiographic success (%) 34 (100)
Periprocedure MI 0
In-hospital MACE 0
30-day MACE 0
BMS  bare-metal stent(s); MACE  major adverse cardiac event; MI  myocardial infarction;
PES paclitaxel-eluting stent(s); SES sirolimus-eluting stent(s).
Table 4. Quantitative Coronary Angiographic Analysis
Main Branch Side Branch p Value
Baseline (n  34)
Lesion length, mm 15.5 6.8 11.3 6.1
RVD, mm 3.41 0.72 3.04 0.54
MLD, mm 1.56 0.47 1.33 0.60
Diameter stenosis, % 53.4 11.8 51.4 22.0 0.694
After procedure (n  34)
RVD, mm 3.64 0.58 3.36 0.53
MLD, mm 3.09 0.50 2.98 0.48
Diameter stenosis, % 14.7 8.7 11.2 6.5 0.067
Acute gain, mm 1.47 0.59 1.61 0.63 0.366
Follow-up (n  26)
RVD, mm 3.45 0.58 3.17 0.51
MLD, mm 2.71 0.57 2.21 0.77
Diameter stenosis, % 20.7 12.6 27.4 18.1 0.278
Late lumen loss, mm 0.36 0.65 0.75 0.66 0.139
Restenosis, % 0 2 (7.7) 0.500MLDminimal lumen diameter; RVD reference vessel diameter.s no stent currently available that has a maximum cell
iameter of 5 mm or more (14,15). We believe that this
verlapping strut causes inadequate coverage and expansion
t the ostium of the SB if conventional bifurcation stenting
echniques such as V-stenting, T-stenting, crush stenting,
ulottes stenting, and Y-stenting are used (4–8). In these
echniques, the stent is placed into the SB or an adjunctive
alloon dilation through a stent strut of the MB is required.
ach of these techniques has a limitation when dilating the
stium of the SB from both the overlapping stent strut of
he MB and the crossover stent strut of the SB. However, it
s difficult to get around stenting in the MB in the treatment
f bifurcation lesions. To reduce the interference of strut
nd allow for adequate dilation of the SB ostium, this new
tenting technique, which modifies the proximal edge of the
tent into the SB, was developed.
In the flower petal stenting technique, a proximal strut of
he SB stent is opened widely to resemble a flower petal and
his “petal” does not cross over the ostium of the SB because
Figure 6. Relationship of Diameters of Major Axis at SB Ostium and SB
The theoretical relationship between the diameter of the major axis at side
branch ostium and the diameter of side branch (SB). D  diameter of side
Table 5. Clinical Follow-Up at 9 Months (n  26)
Cumulative MACE (%) 2 (7.7)
Target lesion revascularization (%) 2 (7.7)*
Target bifurcation revascularization (%) 2 (7.7)*
Acute thrombosis 0
Late thrombosis 0
Myocardial infarction 0
Death 0
*All target lesion revascularization and target bifurcation revascularization occurred in reverse
flower stenting cases.
MACEmajor adverse cardiac event.branch.
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64his portion of the stent is turned over into the distal portion
f the MB before stenting in the MB. This technique is
imilar to the minicrush technique (12), T-stenting and
mall protrusion technique stenting (16), and Sleeve tech-
ique (17) because the proximal portion of the SB protrudes
nly slightly into the MB. However, it is not clear how the
ortion becomes protruded in those techniques. With these
echniques, the protruded portion can turn over into the
istal MB, cross over the ostium of the SB, or be crushed at
he carina. Flower petal stenting technique is the only
echnique in which the direction of the protruded section of
he stent can be controlled intentionally. Moreover the petal
overs the carina of the bifurcation, which is one of the sites
n which restenosis occurs often. Also as shown in Figure 3,
here is very little polymer damage with this technique.
This technique can be used for all types of bifurcation
esions; however it involves a bit more procedural complex-
ty. In some lesions where stents were already placed in the
B, this technique is not suitable because the stent struts in
he MB adjacent to the SB ostium interfere in creating the
ower petal effect. Actually, TLR was performed to 2
everse flower stenting cases in this study.
In some cases, we could not insert the stent into the SB
moothly when we used the modified method because the
ires were twisted within the anatomy. In this situation, we
nitially stopped advancing the stent-wire combination sys-
em and pulled back the SBw to the tip of the stent balloon
nd attempted to recross back into the SB without tangling
he wires.
Understanding the limitations of this technique, flower
etal stenting technique can be regarded as the most useful
urrently available technique in the treatment for bifurcation
Figure 7. Difference of Ostial Diameter of SB Varied by Take-Off Angle
Upper panels show the shape of side branch (SB) ostium. The shape of SB ost
lengthened.esions.tudy limitations. We understand that there are limitations
o this study. We identified the indication for this technique
o be lesions with involvement of the SB ostium. Therefore,
he number of patients in this study is too small for any
tatistical differences to be seen. Also, this study was
erformed in a single institution without a control group. A
ulticenter prospective randomized study would be neces-
ary to clearly identify the efficacy of the flower petal
tenting technique.
eprint requests and correspondence: Dr. Yoshihisa Kinoshita,
ivision of Cardiology, Toyohashi Heart Center, 21-1, Gobudori,
yama, Toyohashi, Aichi 441-8530, Japan. E-mail: Ykinoshita@
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